Keros Therapeutics News and Activities

Presence

Keros Therapeutics is a biotechnology company that develops treatments for blood, lung, and muscle diseases. Its products and research services support patients, healthcare providers, and biopharmaceutical partners.

Keros Therapeutics products and services overview:

Biologic therapies
Drug research
Clinical development
Rare disease treatments
Blood disorder treatments
Muscle disease therapies

Revenue: ~$4 million

Employees: 180

Headquarters: Lexington, United States (USA)

Keros Therapeutics is one of the...

Keros Therapeutics is a company listed under the stock ticker KROS (US).

Executives

View the org chart displaying its 15 main executives

Most searched biographies at Keros Therapeutics

Popular executive movements at Keros Therapeutics

Anne Prener will join the company as Director on Jul. 1, 2026 (posted on June 26 2026).
Charles Newton will join the company as Director on Mar. 9, 2026 (posted on February 27 2026).
Ran Nussbaum, Director, has left the company (posted on October 16 2025).

Click here to view some more movements at Keros Therapeutics

Create your alert
to follow the executive moves at Keros Therapeutics.